This is also how I’m reading it, similar to how NSF handles Collaborative proposals, or DoD’s Partnering PI applications

the word alert is in a purple circle ALT: the word alert is in a purple circle

ACTION ITEM-----ACTION ITEM

Implementation of Schedule F

This is what a lot of us have been worried about.

This allows for many civil service positions to replaced with political appointees. This could include NIH institute directors and even POs.

BUT THERE IS A COMMENT PERIOD...

1/n

I’m so sorry

Great thread discussing the impact of NIH’s plan to centralize review with CSR

From an NIH source re. grant terminations

"These searches are pulling in things based on 'other support' sections and biosketches, so science may be held up just because someone mentions that they serve on a DEIA committee, or has a completely different grant that uses a 'problematic' word.

(cont)

Do you have any insight into what impacts this will have on IC-specific P30, P50 applications?

Judge issues preliminary injunction blocking Trump cuts to NIH research overhead payments A federal judge issued a nationwide preliminary injunction blocking the Trump administration from slashing NIH payments for research overhead

Judge issues preliminary injunction blocking Trump cuts to NIH research overhead payments #RAdminsky www.statnews.com/2025/03/05/n... via @statnews.com

💙💙💙

Thank you!! I couldn’t figure it out either 🤣🤣

I was trying not to doom scroll today but HOLY SHIT.

Inside the Collapse at NIH Administration officials pressured NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.

I talked to NIH officials, current and former, about what's been happening inside the agency since the Trump administration shut down their grantmaking pipeline in January. Their stories showed just how willing our new leaders are to break the law: www.theatlantic.com/health/archi...

It seems to be dependent on the IC. I’ve got two pending awards from NCI that are just waiting on final processing for a March 1 (hopefully) start. The GMS and PO were very responsive during collection of final docs, but not sure what happens after they finalize on their end…

In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.

An #NIH-funded research team has developed an mRNA vaccine to treat pancreatic cancer. Results from the clinical trial were published this week in Nature.

#pancreas #cancer #mRNA #vaccine #medsky #science #medicine #bluesky

Elon Musk instructed federal workers to respond to an email summarizing their weekly accomplishments, a tactic he previously used to downsize staff at X. “Please reply to this email with approximately five bullet points of what you accomplished this week and CC your manager,” the message stated.